A Multi-Dose Study to Assess Tolerability, Safety and Pharmacology of hGH-ViaDerm™ System in Adults With GH-Deficiency
This study has been completed.
Teva Neuroscience, Inc.
Teva Pharmaceutical Industries
Information provided by (Responsible Party):
Teva Pharmaceutical Industries ( Teva Neuroscience, Inc. )
First received: April 2, 2007
Last updated: August 30, 2013
Last verified: April 2009
No Study Results Posted on ClinicalTrials.gov for this Study
|Study Status:||This study has been completed.|
|Study Completion Date:||No date given|
|Primary Completion Date:||October 2007 (Final data collection date for primary outcome measure)|